We are live on ! Find out more
RYTM icon

Rhythm Pharmaceuticals
RYTM

91 hedge funds and large institutions have $920M invested in Rhythm Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 38 increasing their positions, 18 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

111% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 18

110% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 10

48% more capital invested

Capital invested by funds: $621M → $920M (+$298M)

14% more funds holding

Funds holding: 80 → 91 (+11)

0.91% more ownership

Funds ownership: 92.62% → 93.53% (+0.91%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
91
Holders Change
+11
Holders Change %
+13.75%
% of All Funds
1.87%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
21
Increased
38
Reduced
18
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MWNA
Marshall Wace North America
New York
+$5.88M
2
BlackRock
BlackRock
New York
+$5.82M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$5.07M
4
Bank of America
Bank of America
North Carolina
+$4.09M
5
State Street
State Street
Massachusetts
+$3.1M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$10.9M
2
MAM
MPM Asset Management
Massachusetts
-$8.77M
3
RCM
RA Capital Management
Massachusetts
-$4.14M
4
PA
Perceptive Advisors
New York
-$2.6M
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$1.39M
Name Holding Trade Value Shares
Change 		Change in
Stake
N
26
Nuveen
North Carolina
$2.63M +$218K +11,181 +10%
Aviva
27
Aviva
United Kingdom
$2.51M -$387K -19,869 -15%
Barclays
28
Barclays
United Kingdom
$2.27M +$158K +8,127 +9%
JP Morgan Chase
29
JP Morgan Chase
New York
$2.14M -$159K -8,145 -8%
Bessemer Group
30
Bessemer Group
New Jersey
$1.93M +$906K +46,500 +117%
California Public Employees Retirement System
31
California Public Employees Retirement System
California
$1.52M +$50.2K +2,573 +4%
MP
32
Mangrove Partners
Connecticut
$1.27M +$1.11M +57,138 New
Swiss National Bank
33
Swiss National Bank
Switzerland
$1.2M -$109K -5,600 -9%
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
$1.13M +$105K +5,397 +12%
State of Wisconsin Investment Board
35
State of Wisconsin Investment Board
Wisconsin
$1.12M +$50.7K +2,600 +5%
RhumbLine Advisers
36
RhumbLine Advisers
Massachusetts
$995K +$197K +10,124 +29%
AllianceBernstein
37
AllianceBernstein
Tennessee
$921K +$329K +16,900 +69%
BGIM
38
Brandywine Global Investment Management
Pennsylvania
$920K +$7.08K +363 +0.9%
RHJA
39
Rice Hall James & Associates
California
$830K -$482K -24,704 -40%
CS
40
Credit Suisse
Switzerland
$826K +$447K +22,915 +162%
TRSOTSOK
41
Teachers Retirement System of the State of Kentucky
Kentucky
$793K – – –
PPA
42
Parametric Portfolio Associates
Washington
$785K +$96K +4,923 +16%
New York State Common Retirement Fund
43
New York State Common Retirement Fund
New York
$743K +$78K +4,000 +14%
Goldman Sachs
44
Goldman Sachs
New York
$738K -$367K -18,841 -36%
AC
45
Athanor Capital
New York
$588K +$514K +26,349 New
Morgan Stanley
46
Morgan Stanley
New York
$548K +$262K +13,451 +121%
Citigroup
47
Citigroup
New York
$520K +$64.3K +3,299 +16%
Wells Fargo
48
Wells Fargo
California
$480K +$127K +6,492 +43%
AIG
49
American International Group
New York
$458K +$62.5K +3,209 +18%
Manulife (Manufacturers Life Insurance)
50
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$444K +$22.1K +1,134 +6%
1
2
3 4 5

RYTM Hedge Fund Activity: Q2 2020 in Review

91 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Rhythm Pharmaceuticals (RYTM) for Q2 2020, worth a combined $920M — up 48% from $621M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new RYTM positions and 10 closed out — a net gain of 11 holders — while 38 added to existing stakes and 18 trimmed.

The largest buyer was Marshall Wace North America, opening a new position worth an estimated $5.88M. The largest seller was Deerfield Management, cutting an estimated $10.9M.

  • 91 institutional investors held Rhythm Pharmaceuticals (RYTM) as of Q2 2020, up from 80 in Q1 2020.
  • Funds reported $920M of Rhythm Pharmaceuticals stock for Q2 2020, up 48% quarter-over-quarter.
  • 21 funds opened new Rhythm Pharmaceuticals positions in Q2 2020 and 10 closed out, a net change of +11 holders.
  • The largest Rhythm Pharmaceuticals buyer in Q2 2020 was Marshall Wace North America, an estimated $5.88M added.
  • The largest Rhythm Pharmaceuticals seller in Q2 2020 was Deerfield Management, an estimated $10.9M sold.

Based on aggregated 13F filings for Q2 2020.